首页> 外国专利> POLYPEPTIDE OR POLYPEPTIDE CONSTRUCT COMPRISING AT LEAST ONE SINGLE DOMAIN ANTIBODY DIRECTED AGAINST VON WILLEBRAND FACTOR, A COMPOSITION COMPRISING IT, A NUCLEIC ACID ENCODING IT AND ITS USES IN THE PREPARATION OF A MEDICAMENT FOR PREVENTION AND/OR ALLEVIATION OF CONDITIONS OF PLATELET MEDIATED AGGREGATION

POLYPEPTIDE OR POLYPEPTIDE CONSTRUCT COMPRISING AT LEAST ONE SINGLE DOMAIN ANTIBODY DIRECTED AGAINST VON WILLEBRAND FACTOR, A COMPOSITION COMPRISING IT, A NUCLEIC ACID ENCODING IT AND ITS USES IN THE PREPARATION OF A MEDICAMENT FOR PREVENTION AND/OR ALLEVIATION OF CONDITIONS OF PLATELET MEDIATED AGGREGATION

机译:多肽或多肽结构至少由一个单域抗体构成,针对冯·威勒伯兰德因子,包含一种成分,一种编码核酸的成分及其在制备用于预防和/或治疗该疾病的药物中的用途

摘要

The present invention relates to polypeptides comprising at least one single domain antibody directed against vWF, vWF A1 domain, A1 domain of activated vWF, vWF A3 domain, gpIb and/or collagen, for the treatment for conditions which require a modulation of platelet-mediated aggregation. A further aspect of the invention is methods of production of said polypeptides, methods to coat devices with such polypeptides used in medical procedures (e.g. PCTA, stenting) and kits for the diagnosis of diseases related to platelet-mediated aggregation.
机译:本发明涉及包含至少一种针对vWF,vWF A1结构域,活化的vWF的v1 A1结构域,vWF A3结构域,gpIb和/或胶原的单结构域抗体的多肽,用于治疗需要调节血小板介导的疾病聚合。本发明的另一方面是产生所述多肽的方法,用在医疗程序中使用的这种多肽包被装置的方法(例如PCTA,支架术),以及用于诊断与血小板介导的聚集有关的疾病的试剂盒。

著录项

  • 公开/公告号IL169068A

    专利类型

  • 公开/公告日2012-05-31

    原文格式PDF

  • 申请/专利权人 ABLYNX N.V.;

    申请/专利号IL20050169068

  • 发明设计人

    申请日2005-06-08

  • 分类号

  • 国家 IL

  • 入库时间 2022-08-21 17:24:50

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号